What is the recommended dosage and administration schedule for the anti-rabies vaccine (intramuscular injection) in adults and children, regardless of previous vaccination history, after exposure to rabies?

Rabies Post-Exposure Prophylaxis Dosing

For previously unvaccinated individuals after rabies exposure, administer 4 doses of rabies vaccine (1.0 mL intramuscularly) on days 0,3,7, and 14, combined with human rabies immune globulin (HRIG) at 20 IU/kg body weight on day 0, with as much of the HRIG dose as anatomically feasible infiltrated directly into and around the wound. 1, 2, 3

Standard Post-Exposure Prophylaxis Regimen

Vaccine Administration

• Dose and schedule: Administer 1.0 mL of human diploid cell vaccine (HDCV) or purified chick embryo cell vaccine (PCECV) intramuscularly on days 0,3,7, and 14 1, 2, 4, 3
• Day 0 definition: Day 0 is the day the first dose is administered, not necessarily the day of exposure 1, 4
• Injection site for adults and older children: Deltoid muscle only 1, 2, 3
• Injection site for young children: Anterolateral thigh 1, 2, 3
• Critical pitfall: Never use the gluteal area for vaccine administration, as this produces inadequate antibody response and has been associated with vaccine failures 1, 2, 4, 3

Rabies Immune Globulin (HRIG) Administration

• Dose: 20 IU/kg body weight, administered once on day 0 5, 1, 2, 3
• Timing: Ideally given simultaneously with the first vaccine dose, but can be administered up to and including day 7 after the first vaccine dose if initially missed 5, 1, 3
• Wound infiltration: Infiltrate the full calculated dose around and into the wound(s) if anatomically feasible 5, 1, 2, 3
• Remaining volume: Any volume that cannot be infiltrated into the wound should be administered intramuscularly at a site distant from vaccine administration 5, 1, 3
• Critical pitfall: Never administer HRIG in the same syringe or at the same anatomical site as the vaccine 1, 2, 4, 3
• Dosing warning: Do not exceed 20 IU/kg, as higher doses suppress active antibody production 5, 1, 2

Modified Regimens for Special Populations

Previously Vaccinated Individuals

• Simplified regimen: Only 2 doses of vaccine (1.0 mL each) on days 0 and 3 1, 2, 4, 3
• No HRIG needed: Previously vaccinated persons should NOT receive HRIG, as it will inhibit the anamnestic antibody response 1, 2, 4
• Definition of previously vaccinated: Anyone who has completed a recommended pre-exposure or post-exposure vaccination series with a cell culture vaccine 2, 3

Immunocompromised Patients

• Extended regimen: 5 doses of vaccine on days 0,3,7,14, and 28, plus HRIG at 20 IU/kg on day 0 1, 2, 4
• Applies even if previously vaccinated: Immunocompromised patients require the full 5-dose regimen with HRIG regardless of prior vaccination history 1, 2, 4
• Mandatory serologic testing: Antibody titers must be checked 1-2 weeks after the final dose to confirm adequate response 1

Pediatric Patients

• Same dose volume: Children receive the same 1.0 mL vaccine dose as adults 1, 2, 4
• Same HRIG dose: 20 IU/kg body weight applies to all ages, including children 5, 1, 2

Essential Wound Care (First Step)

• Immediate washing: Thoroughly wash all wounds with soap and water for 15 minutes before administering any biologics 1, 2, 4
• Virucidal irrigation: Follow with irrigation using povidone-iodine solution if available 1, 2, 3
• Rationale: This single intervention markedly reduces rabies risk and is perhaps the most effective measure for preventing infection 1, 4

Critical Timing Considerations

• Initiate immediately: Begin PEP as soon as possible after exposure, ideally within 24 hours 1, 2, 4
• No absolute cutoff: Treatment should be administered regardless of time elapsed since exposure, as rabies is uniformly fatal once symptoms appear and incubation periods can exceed one year 1, 4
• Schedule flexibility: Delays of a few days for individual doses are unimportant and do not compromise protection 1, 4

Common Clinical Pitfalls to Avoid

• Never use gluteal injection site: This is associated with inadequate immune response and vaccine failure 1, 2, 4, 3
• Never give HRIG to previously vaccinated persons (unless immunocompromised): This suppresses the memory immune response 1, 2, 4
• Never exceed 20 IU/kg HRIG: Higher doses suppress active antibody production 5, 1, 2
• Never administer HRIG and vaccine in the same syringe or anatomical location 1, 2, 4, 3
• Never administer HRIG after day 7: Beyond day 7, vaccine-induced antibodies are presumed to have developed, making HRIG unnecessary and potentially suppressive 5, 1

Efficacy

When administered promptly and appropriately, this combined regimen of wound care, HRIG infiltration, and the vaccine series is nearly 100% effective in preventing human rabies 1, 4. The reduction from the historical 5-dose to the current 4-dose schedule is supported by extensive evidence showing that neutralizing antibodies peak by day 14-28, making the fifth dose unnecessary for immunocompetent individuals 6.